Clinical Trial

The Effect of Dexmedetomidine Infusion Alone Versus the Combination of Dexmedetomidine and Melatonin on Reduction of Post-operative Delirium (POD) After Open Brain Surgeries

Completed Phase 4
View on ClinicalTrials.gov →
Summary
The aim of this study is to illuminate the effect of combination of dexmedetomidine and oral melatonin versus the use of dexmedetomidine infusion alone on the improving of post-operative delirium (POD) on patients undergoing open brain surgeries.
Trial Details
NCT Number NCT07475156
Lead Sponsor Ain Shams University
Conditions Post Operative Delerium
Enrollment 100 participants
Start Date 2025-08-01
Primary Completion 2026-01-15 (estimated)
Study Completion 2026-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-16